PROFUSA, INC. Increase (Decrease) in Derivative Liabilities
PROFUSA, INC. (PFSA) reported Increase (Decrease) in Derivative Liabilities of -$6.36 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2023-03-06
- PROFUSA, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-12-31 was -$111.34K.
- PROFUSA, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-09-30 was -$1.07M.
- PROFUSA, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-06-30 was -$1.29M.
- PROFUSA, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-03-31 was -$3.88M.
- PROFUSA, INC. increase (decrease) in derivative liabilities for fiscal 2022 was -$6.36M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 8 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | -$111.34K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$1.19M derived: sum of 2 quarters · filed 2023-03-06 | -$2.48M derived: sum of 3 quarters · filed 2023-03-06 | -$6.36M 10-K · filed 2023-03-06 | |
| 2022-09-30 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$2.37M derived: sum of 2 quarters · filed 2022-11-10 | -$6.25M 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$5.17M 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | -$3.88M 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | -$597.57K 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |